XML 38 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Summary of Fair Value by Major Security Type The following table summarizes, by major security type, our cash, cash equivalents, restricted cash, and marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in millions):
 December 31, 2022
  
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Total
Estimated
Fair Value
Cash$10,666 $— $— $10,666 
Level 1 securities:
Money market funds27,899 — — 27,899 
Equity securities (1)3,709 
Level 2 securities:
Foreign government and agency securities537 — (2)535 
U.S. government and agency securities2,301 — (155)2,146 
Corporate debt securities23,111 — (484)22,627 
Asset-backed securities2,721 — (149)2,572 
Other debt securities249 — (12)237 
$67,484 $— $(802)$70,391 
Less: Restricted cash, cash equivalents, and marketable securities (2)(365)
Total cash, cash equivalents, and marketable securities$70,026 
 December 31, 2023
  
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Total
Estimated
Fair Value
Cash$11,706 $— $— $11,706 
Level 1 securities:
Money market funds39,160 — — 39,160 
Equity securities (1)4,658 
Level 2 securities:
Foreign government and agency securities505 — — 505 
U.S. government and agency securities1,789 (91)1,699 
Corporate debt securities27,996 — (191)27,805 
Asset-backed securities1,707 — (61)1,646 
Other debt securities108 — (4)104 
$82,971 $$(347)$87,283 
Less: Restricted cash, cash equivalents, and marketable securities (2)(503)
Total cash, cash equivalents, and marketable securities$86,780 
___________________
(1)The related unrealized gain (loss) recorded in “Other income (expense), net” was $11.6 billion, $(13.6) billion, and $1.0 billion for the years ended December 31, 2021, 2022, and 2023.
(2)We are required to pledge or otherwise restrict a portion of our cash, cash equivalents, and marketable debt securities primarily as collateral for real estate, amounts due to third-party sellers in certain jurisdictions, debt, and standby and trade letters of credit. We classify cash, cash equivalents, and marketable debt securities with use restrictions of less than twelve months as “Accounts receivable, net and other” and of twelve months or longer as non-current “Other assets” on our consolidated balance sheets. See “Note 7 — Commitments and Contingencies.”
Summary of Gross Realized Gains (Losses) on Investments
The following table summarizes gross gains and gross losses realized on sales of marketable debt securities (in millions):
Year Ended December 31,
202120222023
Realized gains$85 $43 $
Realized losses38 341 67 
Summary of Contractual Maturities of Investments
The following table summarizes the remaining contractual maturities of our cash equivalents and marketable debt securities as of December 31, 2023 (in millions):
Amortized
Cost
Estimated
Fair Value
Due within one year$65,224 $65,159 
Due after one year through five years4,635 4,430 
Due after five years through ten years411 394 
Due after ten years995 936 
Total$71,265 $70,919 
Actual maturities may differ from the contractual maturities because borrowers may have certain prepayment conditions.
Consolidated Statements of Cash Flow Reconciliation - Cash and Cash Equivalents
The following table provides a reconciliation of the amount of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows (in millions):
December 31, 2022December 31, 2023
Cash and cash equivalents$53,888 $73,387 
Restricted cash included in accounts receivable, net and other358 497 
Restricted cash included in other assets
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows$54,253 $73,890 
Consolidated Statements of Cash Flow Reconciliation - Restricted Cash
The following table provides a reconciliation of the amount of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows (in millions):
December 31, 2022December 31, 2023
Cash and cash equivalents$53,888 $73,387 
Restricted cash included in accounts receivable, net and other358 497 
Restricted cash included in other assets
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows$54,253 $73,890